Kawasaki, Japan

Hirokazu Ueno

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Ea Pharma Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hirokazu Ueno. Retrieved from https://idiyas.com/inventor/hirokazu-ueno-gycaovhn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hirokazu Ueno: Pioneering Inventor from Kawasaki, JP

Introduction: Hirokazu Ueno is a renowned inventor hailing from Kawasaki, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Hirokazu Ueno holds several patents in the areas of robotics, artificial intelligence, and sustainable energy solutions, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Hirokazu Ueno has worked with leading tech companies in Japan, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Hirokazu Ueno has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge-sharing.

Conclusion: Hirokazu Ueno's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true trailblazer in the world of inventions, inspiring the next generation of inventors to dream big and create a better future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…